Equities

Vijaya Diagnostic Centre Ltd

VIJAYA:NSI

Vijaya Diagnostic Centre Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)1,038.20
  • Today's Change17.20 / 1.68%
  • Shares traded268.33k
  • 1 Year change+68.02%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 10:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Vijaya Diagnostic Centre Ltd grew revenues 19.29% from 4.59bn to 5.48bn while net income improved 40.40% from 846.32m to 1.19bn.
Gross margin87.79%
Net profit margin21.26%
Operating margin29.71%
Return on assets13.00%
Return on equity20.06%
Return on investment14.40%
More ▼

Cash flow in INRView more

In 2024, cash reserves at Vijaya Diagnostic Centre Ltd fell by 19.29m. However, the company earned 1.85bn from its operations for a Cash Flow Margin of 33.76%. In addition the company used 1.42bn on investing activities and also paid 445.50m in financing cash flows.
Cash flow per share19.25
Price/Cash flow per share52.82
Book value per share70.64
Tangible book value per share56.94
More ▼

Balance sheet in INRView more

Vijaya Diagnostic Centre Ltd has a Debt to Total Capital ratio of 28.60%, a lower figure than the previous year's 40.00%.
Current ratio2.36
Quick ratio2.30
Total debt/total equity0.4023
Total debt/total capital0.286
More ▼

Growth rates in INR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 40.35%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)6.95%
EPS growth(5 years)20.84
EPS (TTM) vs
TTM 1 year ago
28.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.